IE
AEMD icon

Israel Englander’s Aethlon Medical AEMD Stock Holding History

Israel Englander’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10
Closed -$16K – 6048
2023
Q1 		$16K Buy
10
+2
+25% +$3.77K ﹤0.01% 5917
2022
Q4 		$9K Buy
+8
New +$14.6K ﹤0.01% 6200
2021
Q2 		– Sell
-4
Closed -$30K – 6456
2021
Q1 		$30K Buy
+4
New +$38.5K ﹤0.01% 5804
2018
Q3 		– Sell
-3
Closed -$256K – 3855
2018
Q2 		$256K Hold
3
– – ﹤0.01% 3457
2018
Q1 		$238K Buy
+3
New +$265K ﹤0.01% 3309
2015
Q4 		– Hold
0
– -$98K – 3370
2015
Q3 		– Hold
0
– – – 3275

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AFGAS
Allegiance Financial Group Advisory Services Vienna, Virginia $578M AUM 24.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Israel Englander's AEMD Position: Q2 2023 in Review

Israel Englander sold out of Aethlon Medical (AEMD) in Q2 2023, closing a stake of 10 shares — an estimated $16K sold.

Israel Englander first reported a position in AEMD in Q1 2018 and held it in 5 quarters. The position peaked at $256K in Q2 2018. 18 funds tracked by Wall St. Rank hold AEMD as of Q2 2023.

  • Israel Englander reported no remaining Aethlon Medical position as of Q2 2023 after selling out during the quarter.
  • Israel Englander sold 10 Aethlon Medical shares in Q2 2023, an estimated $16K.
  • Israel Englander first reported a position in Aethlon Medical in Q1 2018 and held it in 5 quarters.
  • Israel Englander's Aethlon Medical position peaked at $256K in Q2 2018.
  • 18 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.